Navigation Links
Preliminary Phase 2 Data of Ocera Therapeutics' OCR-002 for the Treatment of Liver Cirrhosis and Upper GI Bleeding Show Potent Ammonia Reduction
Date:5/29/2012

BARCELONA, Spain and SAN DIEGO, May 29, 2012 /PRNewswire/ --- Hospital Universitari Vall d'Hebron Research Institute in Barcelona and Ocera Therapeutics, Inc. announced today preliminary data from an open label phase 2 study evaluating the overall effectiveness and safety of OCR-002 (ornithine phenylacetate) for the treatment of cirrhosis of the liver and upper GI bleeding. An interim analysis of the first cohort of patients demonstrated that OCR-002 is well tolerated and provided a rapid and durable ammonia reduction after 36 hours of treatment. The data were presented at the 15th International Symposium for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) in Grenaa, Denmark.

OCR-002 is a novel injectable agent that removes toxic, circulating ammonia from the blood. In patients with severe liver impairment, ammonia and other toxic substances that are normally removed by the liver accumulate in the blood and impair the function of brain cells. By removing circulating ammonia, OCR-002 may treat or prevent hepatic encephalopathy (HE), a neuropsychiatric complication of acute liver failure associated with increased levels of circulating ammonia. Signs of HE include impaired cognition, uncontrolled movements and decreased levels of consciousness leading to coma and even death.

"These early data demonstrate that OCR-002 is well tolerated, rapidly normalizes hyperammonemia and has the potential to prevent the development of hepatic encephalopathy," said Dr. Juan Cordoba of Hospital Universitari Vall d'Hebron and the lead investigator of the study. "Cirrhosis patients that present with acute upper gastrointestinal bleeding have a 30% chance of developing hepatic encephalopathy and require intensive care. A medicine that can quickly remove the toxic ammonia may help prevent or reverse this life-threatening condition, minimize the need for intensive care and shorten hospitalization."

The data presented today from the study of Upper GI bleed in
'/>"/>

SOURCE Ocera Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
2. Cardinal Health Statement in Response to Preliminary Injunction Hearing February 29, 2012
3. Vermillion to Report Preliminary Results for Fourth Quarter and Fiscal Year 2011 on February 23, 2012
4. Watson Confirms Court Stays Preliminary Injunction
5. Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
6. Hill-Rom Announces Preliminary Fiscal First Quarter Financial Results; Updates 2012 Financial Outlook
7. Volcano Corporation Announces Preliminary Fourth Quarter 2011 Revenues
8. CareFusion Announces Preliminary Second Quarter Results
9. Sanofi Announces Court Ruling Granting Preliminary Injunction Against Synvisc-One® Competitor Product
10. InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
11. PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... ANDOVER, Mass. , Aug. 30, 2014   ... launch of Affiniti, a new ultrasound system ... overcome the demands of increasing patient volumes and cost ... Cardiology (ESC) Congress 2014 in Barcelona ... radiology/ultrasound departments facing more patients with fewer resources deliver ...
(Date:8/29/2014)... DALLAS , Aug. 29, 2014 /PRNewswire-iReach/ -- ... Crystallography Scanner Industry, 2009-2019 is a professional and ... X-Ray Crystallography Scanner industry . The report firstly ... including its classification, application and manufacturing technology. The ... of X-Ray Crystallography Scanner listing their product specification, ...
(Date:8/29/2014)... ANGELES , Aug. 29, 2014  Chuma ... both financing alternatives and turnkey support services for ... announce that FINRA processed and approved the Company,s ... 29, 2014, CannaMed Corporation will be known as ... change was accomplished through a merger with the ...
Breaking Medicine Technology:Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3
... 16, 2011  Kensey Nash Corporation (NASDAQ: KNSY ) ... to enter into non-binding mediation in an attempt to resolve ... Angio-Seal vascular closure device, as well as other related claims. ... are currently to be paid, and should since 2007 have ...
...  Pharmasset, Inc. (Nasdaq: VRUS ) announced today ... QUANTUM Phase 2b trial of the guanine nucleotide analog ... containing PSI-938. There are 235 individuals with hepatitis C ... with PSI-938 alone or in combination with PSI-7977 or ...
Cached Medicine Technology:Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes 2Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes 3Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes 4Pharmasset Announces Intent to Amend QUANTUM Trial 2Pharmasset Announces Intent to Amend QUANTUM Trial 3
(Date:8/30/2014)... 30, 2014 Ticket Down ... Tennis Championship tickets in NYC. This popular ... US-OPEN-2014 for all day session, evening session, courtside seats, ... for this prestigious Grand Slam Tournament. , The 2014 ... , US Open Tennis Championship: Men's/Women's 3rd Round - ...
(Date:8/30/2014)... 30, 2014 The establishment and ... has been one of the main strategies of ... a positive impact around the world. , Architecturally ... top trained executives and trainers deliver L. Ron ... Vital statistics demonstrate that significant reduction in ...
(Date:8/30/2014)... August 30, 2014 After offering ... country for the past several years, Dr. Roy ... Center have announced a scholarship program for veterans ... follows a meeting held this summer to discuss ... years, reporters have shed light on the large ...
(Date:8/30/2014)... 30, 2014 Acne is a common problem millions ... is nothing more than a daily nuisance, for some, it can ... of acne can even lead to dramatic mood swings and depression. ... anything to clear up their skin. In some cases, that can ... through trial and error, those on a quest for clearer skin ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Market ... Industry, 2009-2019 is a professional and in-depth market ... The report firstly reviews the basic information of ... technology. The report then explores global and China’s ... specification, capacity, Production value, and market share etc. ...
Breaking Medicine News(10 mins):Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 2Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 3Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 4Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 5Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4
... in two men and one in three women, cancer remains ... This year, in the nation,s capital, the American Association for ... draw more than 17,000 academics, scientists, clinicians, industry leaders, survivors ... findings in this fast-moving arena. To help you ...
... Remedi ... Ohio long-term care marketplace. , ... Baltimore, Md. (PRWEB) February 4, 2010 -- Remedi SeniorCare has expanded its ... new customers for its comprehensive pharmacy services., , ,Vista Grande Villa of Jackson, Michigan, ...
... 50 ... “text to” donation number on February 6th to heighten awareness about the Haitian crisis ... ... nonprofit dedicated to providing health care services to underprivileged children in resource limited countries, ...
... to preventive treatment, researchers say , THURSDAY, Feb. 4 ... in mothers and fetuses that appear to boost the ... traits are found in genes that regulate inflammation -- ... material that holds cells within tissues. , "A ...
... ... a perfect one of a kind Valentines gift. , ... Naperville, IL (PRWEB) February 4, 2010 -- The concept of ... couples to spend wonderful time away from distractions while enjoying fellowship with other couples and ...
... , As Lower-Cost Methadone Prescribing Increases, ... Feb. 4 In a unique and ... -- 2009, the deaths involving methadone were found to be ... opioid prescriptions but is responsible for a third of the ...
Cached Medicine News:Health News:Two Long-Term Care Organizations Select Remedi SeniorCare for Pharmacy Services 2Health News:Two Long-Term Care Organizations Select Remedi SeniorCare for Pharmacy Services 3Health News:One5 Foundation Launches National Haitian Relief Campaign with TShirtAds 2Health News:One5 Foundation Launches National Haitian Relief Campaign with TShirtAds 3Health News:The Love Convention Returns With "Something New" at Hotel Arista on Valentines Weekend 2Health News:The Love Convention Returns With "Something New" at Hotel Arista on Valentines Weekend 3Health News:Methadone and Other Opioids Not Always Equivalent, Conversion Can Be Lethal 2Health News:Methadone and Other Opioids Not Always Equivalent, Conversion Can Be Lethal 3Health News:Methadone and Other Opioids Not Always Equivalent, Conversion Can Be Lethal 4
Console Horizontal Airflow Cabinet...
... Ideal for biocompatibility testing at various ... of air through a clean heating ... temperature up to 140F. Transparent panels ... shields allow easy access to the ...
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
Medicine Products: